Database : HANSEN
Search on : SULFONAS/FARMACOL [Subject descriptor]
References found : 23 [refine]
Displaying: 1 .. 20   in format [Detailed]

page 1 de 2 go to page        

  1 / 23 HANSEN  
              next record last record
select
to print
Texto Completo-en
Id:18755
Author:Almeida, José Oliveira de; Carvalho, Renato P. Souza; Padron, Consuelo.
Title:Complement-fixing antibodies in the sera of 534 lepromatous lepers under treatment with sulfones.
Source:Rev. bras. Leprol;24(3):17-26, set. 1956. ^btab.
Abstract:Reações de fixação de comoplemento, com ant¡geno preparado de bacilos da tuberculose, foram praticadas em soros de 534 leprosos. A reatividade sérica foi medida em unidades de complemento necessárias para 50% de hemólise, quando 0,05 ml de sôro reagia com antígeno diluído para dar reações de máxima intensidade. O título do sôro foi determinado empregando seis unidades de complemento e partes alíquotas de sôro. Considerando haver proporção entre complemento necessário para 50% de hemólise e a quantidade de sôro presente na reação, o título foi determinado com sôro diluído, em presença de antígeno e seis unidades de complemento. Os pacientes puderam ser classificados em três grupos distintos: o primeiro grupo compreendia 74 leprosos recentemente internados no Sanatório Padre Bento (Gopouva, São Paulo), com baciloscopia positiva nas lesões e no muco nasal; neste grupo somente 19% apresentaram títulos menores que 10, 51% dêles estavam entre 10, 100, e 30% eram maiores de 100. O segundo grupo compunha se de 217 pacientes submetidos a tratamento por sulfonas, com baciloscopia positiva apenas nas lesões; neste grupo 33% dos títulos eram menores que 10 e 100 e 15% eram maiores que 100. O terceiro grupo era formado de doentes em alta, mas ainda sob tratamento, apresentando baciloscopia negativa nas lesões e no muco nasal. A maior percentagem de títulos menores que 10, totalizando 70% dos 243 doentes examinados, caracterizou êste grupo; títulos maiores que 100 em apenas 3% e títulos entre 10 e 100 compreenderam 27% dos casos...(AU)^ipt.
Descriptors:Hanseníase/quimioter
Hanseníase/imunol
Hanseníase/fisiopatol
Sulfonas/imunol
Sulfonas/farmacol
Sulfonas/uso terap
Limits:Humanos
Electronic Medium:http://hansen.bvs.ilsl.br/textoc/revistas/brasleprol/1956/PDF/v24n3/v24n3a02.pdf / en
Location:BR191.1


  2 / 23 HANSEN  
              first record previous record next record last record
select
to print
Texto Completo-pt
Id:18737
Author:Lima, Lauro de Souza.
Title:Considerações sobre o real valor da sulfonoterapia nos programas de profilaxia da lepra.
Source:Rev. bras. Leprol;36(1/4):31-36, 1968-1969. .
Abstract:O A. tece considerações sobre o real valor da sulfonoterapia nos programas de profilaxia da lepra baseado nos resultados desse tratamento dos casos contagiantes (Tipo Lepromatoso e Grupo Dimorfo) e dos pacientes do Grupo Indeterminado, não contagiantes, que representam a matriz da endemia. No que concerne aos casos contagiantes demonstra a impossibilidade de, pelo tratamento, conseguir o contrôle da endemia, dado o longo período necessário para torná-los negativos (5 a 10 anos), durante os quais, ainda permanecem infectantes, e a circunstância de apenas uma pequena proporção de casos contagiantes conhecidos receber tratamento com a regularidade indispensável para a sua negatividade baciloscópica (70% no primeiro ano, caindo para 25% e menos nos anos seguintes). Por outro lado, mostra que o contrôle da endemia, só poder  ser conseguido a longo prazo, pelo tratamento sulfônico dos casos de Grupo Indeterminado, dada a ação impediente desse tratamento na transformação desses casos não contagiantes em contagiantes. Salienta a possibilidade de desenvolvimento das mutantes sulfono-resistentes, preconizando o tratamento pela tríplice associação de drogas de atividade anti-léprica (sulfona-mãe + tiambutosina + sulfamida de ação prolongada. (AU)^ipt.
Descriptors:Hanseníase/diag
Hanseníase/quimioter
Hanseníase/fisiopatol
Hanseníase/reabil
Sulfonas/anal
Sulfonas/farmacol
Sulfonas/uso terap
Electronic Medium:http://hansen.bvs.ilsl.br/textoc/revistas/brasleprol/1968-1969/PDF/v36n1-4/v36n1-4a03.pdf / pt
Location:BR191.1


  3 / 23 HANSEN  
              first record previous record next record last record
select
to print
Texto Completo-pt
Id:18622
Author:Quagliato, R; Berquó, Elza; Leser, Walter.
Title:Lepromatosos em tratamento sulfônico: 1-Reativações bacterioscópicas. 2- Tempo para negativação..
Source:Rev. bras. Leprol;29(1):19-30, mar. 1961. tag, graf.
Descriptors:Hanseníase/quimioter
Hanseníase/imunol
Hanseníase/fisiopatol
Hanseníase/reabil
Sulfonas/quim
Sulfonas/farmacol
Sulfonas/uso terap
Electronic Medium:http://hansen.bvs.ilsl.br/textoc/revistas/brasleprol/1961/PDF/v29n1/v29n1a03.pdf / pt
Location:BR191.1


  4 / 23 HANSEN  
              first record previous record next record last record
select
to print
Texto Completo-pt
Id:18617
Author:Keffer, Luiza.
Title:Resumos / Summary
Source:Rev. bras. Leprol;23(1/4):114-135, jan.-dec. 1955. .
Descriptors:Sulfonas/anal
Sulfonas/farmacol
Hanseníase/diag
Hanseníase/epidemiol
Hanseníase/imunol
Hanseníase/microbiol
Hanseníase/prev
Hanseníase/fisiopatol
Hanseníase/reabil
Electronic Medium:http://hansen.bvs.ilsl.br/textoc/revistas/brasleprol/1955/PDF/v23n1-4res.pdf / pt
Location:BR191.1


  5 / 23 HANSEN  
              first record previous record next record last record
select
to print
Id:18336
Author:Herrera, Guillermo
Title:Influencia del tratamieto sulfonico sobre el ciclo mestrual y demas funciones de reproduccion en enfermos de lepra consecuencias sobre el produto de la concepcion Influence of the sulfonic treatment on the mestrual cycle and demas functions of reproduction in leprosy patients consequences on product of the conception-
Source:Republica Dominicana; s.n; 1953. 16 p. ilus.
Abstract:Eighteen cases of leprosy affected patients treated with sulfones two to four years had been selected. They presented lepromatous tuberculoid or indeterminated lesions. Doses cycles and tolerance to the drugs have been noted. Wiuth the administration of the sulfonic compounds excellent clinical results were obtained including some cases of total clinical recovery. The lepromin reaction of our patients did not change during treatment...(AU).
Descriptors:SULFONAS/anal
SULFONAS/farmacol
SULFONAS/uso terap
HANSENIASE/quimioter
HANSENIASE/reabil
HANSENIASE/terap
Limits:ESTUDO COMPARATIVO
Location:BR191.1; 00825/s


  6 / 23 HANSEN  
              first record previous record next record last record
select
to print
Id:18323
Author:Pettit, J H S; Rees, R J W
Title:Sulphone resistance in leprosy ..-
Source:s.l; s.n; 1964. 2 p. .
Descriptors:HANSENIASE/quimioter
HANSENIASE/imunol
HANSENIASE/reabil
HANSENIASE/terap
SULFONAS/anal
SULFONAS/farmacol
SULFONAS/uso terap
Limits:ESTUDO COMPARATIVO
Location:BR191.1; 01694/s


  7 / 23 HANSEN  
              first record previous record next record last record
select
to print
Id:18035
Author:Peryri, A
Title:Datos y comentarios la diaminodifenil sulfona em cinco casos Data and commentaries the diaminodifenil sulfona command post five cases-
Source:Monterey; s.n; 1947. 22-41 p. .
Descriptors:HANSENIASE/quimioter
HANSENIASE/imunol
HANSENIASE/fisiopatol
SULFONAS/anal
SULFONAS/quim
SULFONAS/farmacol
Limits:ESTUDO COMPARATIVO
Location:BR191.1; 09404/S


  8 / 23 HANSEN  
              first record previous record next record last record
select
to print
Id:17440
Author:Browne, S. G
Title:The chemotherapy of leprosy ?-
Source:s.l; s.n; s.d. 5p p. .
Descriptors:HANSENIASE/dietoter
HANSENIASE/quimioter
HANSENOSTATICOS/farmacocin
HANSENOSTATICOS/uso terap
SULFONAS/ef adv
SULFONAS/farmacol
SULFONAS/farmacocin
SULFONAS/tox
SULFONAS/uso terap
Limits:RELATO DE CASO
Location:BR191.1; 01105/d.a


  9 / 23 HANSEN  
              first record previous record next record last record
select
to print
Id:17201
Author:S, B. B. M. Dharmendra.
Title:Recent advances in the treatment of leprosy.
Source:Lepr Ind;24(1):4-18, jan., 1952. .
Descriptors:HANSENIASE TUBERCULOIDE/quimioter
HANSENIASE VIRCHOWIANA/quimioter
SULFONAS/admin
SULFONAS/ef adv
SULFONAS/farmacol
SULFONAS/tox
SULFONAS/uso terap
ACIDO SALICILICO/uso terap
 ESTREPTOMICINA/uso terap
Location:BR191.1


  10 / 23 HANSEN  
              first record previous record next record last record
select
to print
Id:17193
Author:Mungavin, J. M.
Title:A review of the relative activity of the sulphones.
Source:Lepr Ind;23(3):161-164, july. 1951. .
Descriptors:HANSENIASE/quimioter
SULFONAS/farmacol
SULFONAS/uso terap
Location:BR191.1


  11 / 23 HANSEN  
              first record previous record next record last record
select
to print
Id:17192
Author:Sen, N; S, B. B. M. Dharmendra; S, N. Chatterjee.
Title:Treatment of leprosy with novotrone.
Source:Lepr Ind;23(3):154-159, july. 1951. tab.
Descriptors:HANSENIASE/quimioter
SULFONAS/admin
SULFONAS/farmacol
Limits:HUMANO
Location:BR191.1


  12 / 23 HANSEN  
              first record previous record next record last record
select
to print
Id:17188
Author:Muir, Ernest.
Title:Bacteriological changes under DDS treatment of leprosy.
Source:Lepr Ind;23(2):116-126, apr., 1951. tab, graf.
Abstract:(1) 4:4' diaminodiphenylsulphone (DDS) has been effective in leprosy in very small amounts. (2) In such is amounts it is not more toxic than its derivatives. (3) The effict is shown of vitamin B12 in controlling reaction and anaemia in cases intolerant to DDS. (4) In 58 cases there was an average improvement of over 20 por cent in the bacillary index, while in 12 cases in which the original bacillary index was 10 or less there was an average improvement of almost 50 per cent. (5) There is evidence that lepra reaction induced by DDS, or by another couse during treatment with DDS, favours the more rapid absorption of lepra bacilli. (6) On this account the advisability is discussed of inducing lepra reaction in cases in which it does not otherwise occur. (7) The question of combining local treatment with DDS therapy is discussed. (8) The oral and parenteral methods of giving DDS are compared (AU).
Descriptors:HANSENIASE/quimioter
SULFONAS/admin
SULFONAS/farmacol
SULFONAS/uso terap
Limits:HUMANO
Location:BR191.1


  13 / 23 HANSEN  
              first record previous record next record last record
select
to print
Id:17136
Author:Anon.
Title:An Apology.
Source:Lepr Ind;16(3):99-102, july, 1944. tab.
Descriptors:HANSENIASE/clas
HANSENIASE/diag
HANSENIASE/quimioter
HANSENOSTATICOS/hist
SULFONAS/admin
SULFONAS/ef adv
SULFONAS/farmacol
Location:BR191.1


  14 / 23 HANSEN  
              first record previous record next record last record
select
to print
Id:17076
Author:Faget, G. H; Pogge, R. C; Johansen, F. A; Fite, George L; Frejean, B. M; Gemar, Frank.
Title:Present status of promin treatment in leprosy.
Source:Int. J. Lepr;14(n.esp):30-36, Dec. 1946. graf.
Descriptors:HANSENIASE/quimioter
HANSENOSTATICOS/hist
SULFONAS/admin
SULFONAS/ef adv
SULFONAS/farmacol
SULFONAS/uso terap
Limits:HUMANO
Location:BR191.1


  15 / 23 HANSEN  
              first record previous record next record last record
select
to print
Id:17075
Author:Fernandez, Jose M. M; Carboni, Eduardo A.
Title:The action of diasone in the treatment of leprosy: preliminary report.
Source:Int. J. Lepr;14(n.esp):19-29, Dec. 1946. tab, ilus.
Abstract:The action of the oral administration of diasone has been studied in a group of advanced cases of leprosy of whom almost all had previously been treated with chaulmoogra oil. The drug was given for periods of 8 weeks with a daily dosage varying between 1 and 3 Grams according to individual tolerance; between each period or course of treatment there was a 4 weeks' interval. Anemia (82 per cent), asthenia and depression (88 per cent), headache (74 per cent) were noted as signs of intolerance. There were no grave consequences and intolerance was readily treated with liver extract, iron, and vitamin B complex. Activity of the drug was shown by softening, ulceration, and re-absorption of leprous nodules, healing of ulcers, and re-absorption of deep lepromatous infiltrations. Bacteriologically, granulation of the bacilli was observed but in no case had bacilli completely disappeared from the lesions. The improvement noted was greater the longer and more concentrated the treatment. The results found after 8 months trial were the following: in 5 cases treated for 3 periods, 100 per cent improved; in 11 cases treated for 2 periods, 63.6 per cent improved; in 26 cases after only 1 period of treatment, 50 per cent improved. Thus of 42 patients who had completed 1 to 3 periods of treatment, 59.5 per cent showed improvement. Finally it may be stated that diasone has proved to be effective in the treatment of leprosy in a series of 42 patients observed for 8 months. Further experimental treatment should be carried out so that definite conclusions based on greater experience can be obtained. (AU).
Descriptors:HANSENIASE/quimioter
HANSENOSTATICOS/hist
SULFONAS/admin
SULFONAS/ef adv
SULFONAS/sangue
SULFONAS/sint quim
SULFONAS/farmacol
SULFONAS/uso terap
Limits:HUMANO
Location:BR191.1


  16 / 23 HANSEN  
              first record previous record next record last record
select
to print
Id:17030
Author:Muir, Ernest.
Title:Preliminary report on diasone in the treatment of leprosy.
Source:Int. J. Lepr;12(n.esp):1-6, Dec. 1944. tab.
Descriptors:HANSENIASE/quimioter
SULFONAS/admin
SULFONAS/farmacol
SULFONAS/uso terap
Location:BR191.1


  17 / 23 HANSEN  
              first record previous record next record last record
select
to print
Id:17025
Author:Faget, G. H; Pogge, R. C; Johansen, F. A; Dinan, J. F; Prejean, B. M; Eccles, C. G.
Title:La prominoterapia de la lepra. Estudios en progreso.
Source:Int. J. Lepr;11(n.esp):52-63, Dec. 1943. ilus, tab.
Descriptors:HANSENOSTATICOS
HANSENIASE/compl
HANSENIASE/quimioter
SULFONAS/admin
SULFONAS/ef adv
SULFONAS/farmacol
SULFONAS/tox
SULFONAS/uso terap
Limits:HUMANO
Location:BR191.1


  18 / 23 HANSEN  
              first record previous record next record last record
select
to print
Id:16645
Author:Faget, G. H; Pogge, R. C.
Title:Treatment of leprosy with-diasone-a preliminary report.
Source:Lepr Ind;18(2):64-68, apr,. 1946. tab.
Descriptors:HANSENIASE/quimioter
HANSENOSTATICOS/hist
SULFONAS/admin
SULFONAS/farmacol
SULFONAS/uso terap
SULFONAS/ef adv
Location:BR191.1


  19 / 23 HANSEN  
              first record previous record next record last record
select
to print
Texto Completo-En
Id:7059
Author:Ghei, S. K; Sengupta, U; Desikan, K. V.
Title:In vitro effect of DDS on phytohaemagglutinin (PHA) induced linphocyte transformation.
Source:Hansen. Int;5(2):112-118, dez. 1980. tab.
Abstract:Estudou-se o efeito do DDS, sobre a transformaçao linfocitaria estimulada pela PHA, in vitro, utilisando-se concentraçoes variaveis de DDS. Os linfocitos foram doados por voluntarios, divididos em tres gupos, e o estudo foi desenvolvido em tres fases. Foram empregadas 4 concentraçoes diferentes de DDS para 10 a sexta de linfocitos em cultura de tecidos alem de 0,02 ml de PHA. Foi observada uma diminuiçao estatisticamente significativa (P<0,05) no percentual de formaçao de celulas blasticas induzida pela PHA com todas as concentraçoes de DDS, exceto com a concentraçao mais baixa (0,01 ug de DDS). Enquanto que a diminuiçao observada na primeira e na terceira fases mostrou-se dependente de dose de DDS, na segunda fase nao se encontrou correlaçao significativa entre a concentraçao de DDS e a depressao da blastogenese induzida pela PHA. Discute-se a significancia destas observaçoes.(AU).
Descriptors:SULFONAS
SULFONAS
FITOHEMAGLUTININAS
 LINFOCITOS
Electronic Medium:http://hansen.bvs.ilsl.br/textoc/hansenint/v01aov20/1980/PDF/v5n2/v5n2a02.pdf / En
Location:BR191.1


  20 / 23 HANSEN  
              first record previous record
select
to print
Id:6969
Author:Floch, Herve Alexandre.
Title:About bioresintance, comparative chemoresistance and sulfono resistance of M. leprae.
Descriptors:HANSENIASE
HANSENIASE
RESISTENCIA A DROGAS
 SULFONAS
 SULFONAS
 SULFONAS
Location:BR191.1



page 1 de 2 go to page        
   


Refine the search
  Database : HANSEN Advanced form   
Search for : Free form   

    Search in field  
1  
2
3
 
           



Search engine: iAH powered by WWWISIS

IAH - © BIREME/PAHO/WHO
Latin American and Caribbean Center on Health Sciences Information